ADial Pharmaceuticals' Unattributed - II Round

ADial Pharmaceuticals raised a round of funding on August 31, 2017.

ADial Pharmaceuticals is focused on developing effective medications to treat addiction and related disorders. The company's most advanced compound AD04 specifically targets Alcohol Use Disorder throu…

Articles about ADial Pharmaceuticals' Unattributed - II Round: